Overcoming disembodiment: The effect of movement therapy on negative symptoms in schizophrenia-a multicenter randomized controlled trial

Frontiers in Psychology

Volumn 7, Issue MAR, 2016, Pages

  Martin, Lily A L ^a,b   Koch, Sabine C ^b,c   Hirjak, Dusan ^d   Fuchs, Thomas ^d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Alanus University   (Germany)

^c SRH UNIVERSITY HEIDELBERG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Body Psychotherapy (BPT); Dance Movement Therapy (DMT); Embodiment disembodiment; Multiple imputation; Negative symptoms; Randomized controlled trial; Schizophrenia

Indexed keywords

EID: 84963657046     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2016.00483     Document Type: Article

References (68)

1. American Dance Therapy Association (2015). Columbia: ADTA. Available online at: http://www.adta.org/About_DMT (Accessed: August 18, 2015).
2. Andreasen, N. C. (1982). Negative symptoms in schizophrenia: definition and reliability. Arch. Gen. Psychiatry 39, 784-788. doi: 10.1001/archpsyc.1982.04290070020005
3. Andreasen, N. C. (1984a). Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa.
4. Andreasen, N. C. (1984b). Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa.
5. Andreasen, N. C., and Olsen, S. (1982). Negative vs. positive schizophrenia: definition and validation. Arch. Gen. Psychiatry 39, 789-794. doi: 10.1001/archpsyc.1982.04290070025006
6. Andrews, G., Sanderson, K., Corry, J., Issakidis, C., and Lapsley, H. (2003). Cost-effectiveness of current and optimal treatment for schizophrenia. Br. J. Psychiatry 183, 427-435. doi: 10.1192/bjp.183.5.427
7. Arango, C., Buchanan, R. W., Kirkpatrick, B., and Carpenter, W. T. (2004). The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur. Psychiatry 19, 21-26. doi: 10.1016/j.eurpsy.2003.10.004
8. Blanchard, J. J., and Cohen, A. S. (2006). The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 32, 238-245. doi: 10.1093/schbul/sbj013
9. Blanchard, J. J., Kring, A. M., Horan, W. P., and Gur, R. (2011). Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr. Bull. 37, 291-299. doi: 10.1093/schbul/sbq104
10. Cacioppo, J. T., Priester, J. R., and Berntson, G. G. (1993). Rudimentary determinants of attitudes: II. Arm flexion and extension have differential effects on attitudes. J. Pers. Soc. Psychol. 65, 5-17. doi: 10.1037/0022-3514.65.1.5
11. Carney, D. R., Cuddy, A. J. C., and Yap, A. J. (2010). Power posing: brief nonverbal displays affect neuroendocrine levels and risk tolerance. Psychol. Sci. 21, 1363-1368. doi: 10.1177/0956797610383437
12. Carpenter, W. T., Heinrichs, D. W., and Alphs, L. D. (1985). Treatment of negative symptoms. Schizophr. Bull. 11, 440-452. doi: 10.1093/schbul/11.3.440
13. Carpenter, W. T., Heinrichs, D. W., and Wagman, A. M. I. (1988). Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 145, 578-583. doi: 10.1176/ajp.145.5.578
14. Chace, M. (1957). "Measurable and intangible aspects of dance sessions, " in Music Therapy: Book of Proceedings (Chicago, IL: National Association for Music Therapy), 151-156.
15. Chakos, M., Lieberman, J., Hoffman, E., Bradford, D., and Sheitman, B. (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Focus 2, 111-121. doi: 10.1176/foc.2.1.111
16. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdale: NJ: Erlbaum.
17. Deutsche Gesellschaft für Psychiatrie Psychotherapie und Nervenheilkunde (DGPPN) (2006). Behandlungsleitlinie Schizophrenie. Darmstadt: Steinkopff Verlag.
18. Eid, M., Gollwitzer, M., and Schmitt, M. (2013). Statistik und Forschungsmethoden. Weinheim: Beltz.
19. Elis, O., Caponigro, J. M., and Kring, A. M. (2013). Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. Clin. Psychol. Rev. 33, 914-928. doi: 10.1016/j.cpr.2013.07.001
20. Enders, C. K. (2010). Applied Missing Data Analysis. New York, NY; London: Guilford Publications.
21. Frith, C. D. (2004). Schizophrenia and theory of mind. Psychol. Med. 34, 385-389. doi: 10.1017/S0033291703001326
22. Fuchs, T. (2005). Corporealized and disembodied minds: a phenomenological view of the body in melancholia and schizophrenia. Philos. Psychiatry Psychol. 12, 95-107. doi: 10.1353/ppp.2005.0040
23. Fuchs, T. (2012). Selbst und schizophrenie. Deutsche Zeitschrift für Philosophie Zweimonatsschrift der Internationalen Philosophischen Forschung 60, 887. doi: 10.1524/dzph.2012.0067
24. Fuchs, T. (2015). From self-disorders to ego disorders. Psychopathology 48, 324-331. doi: 10.1159/000432404
25. Fuchs, T., and Koch, S. C. (2014). Embodied affectivity: on moving and being moved. Front. Psychol. 5:508. doi: 10.3389/fpsyg.2014.00508
26. Fuchs, T., and Schlimme, J. E. (2009). Embodiment and psychopathology: a phenomenological perspective. Curr. Opin. Psychiatry 22, 570-575. doi: 10.1097/YCO.0b013e3283318e5c
27. Gallagher, S. (2005). How the Body Shapes the Mind. Oxford: Oxford University Press.
28. Hall, R. C. W. (1995). Global assessment of functioning: a modified scale. Psychosomatics 36, 267-275. doi: 10.1016/S0033-3182(95)71666-8
29. Hayati Rezvan, P., Lee, K. J., and Simpson, J. A. (2015). The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. BMC Med. Res. Methodol. 15:30. doi: 10.1186/s12874-015-0022-1
30. Heidbüchel, F. (2013). Embodied Intersubjectivity: Effekte von Körperpsychotherapie auf die Negativsymptomatik Schizophrener Patienten. Eine längsschnittliche Analyse des therapeutischen Prozesses. Master Thesis, Ruprecht-Karls-University.
31. Hirjak, D., Thomann, P. A., Kubera, K. M., Wolf, N. D., Sambataro, F., and Wolf, R. C. (2015). Motor dysfunction within the schizophrenia-spectrum: a dimensional step towards an underappreciated domain. Schizophr. Res. 169, 217-233. doi: 10.1016/j.schres.2015.10.022
32. Hirjak, D., Wolf, R. C., Koch, S., Mehl, L., Kelbel, J. K., Kubera, K. M., et al. (2014). Neurological abnormalities in recent-onset schizophrenia and Asperger-Syndrome. Front. Psychiatry 5:91. doi: 10.3389/fpsyt.2014.00091
33. Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., and Marder, S. R. (2006). The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 32, 214-219. doi: 10.1093/schbul/sbj053
34. Koch, S. (2015). Factors of Effectiveness in the Arts Therapies. Heidelberg: SRH Hochschule Heidelberg.
35. Koch, S. C. (2011). Embodiment-Der Einfluss von Eigenbewegung auf Affekt, Einstellung und Kognition. Berlin: Logos Verlag GmbH.
36. Koch, S. C., and Fuchs, T. (2011). Embodied arts therapies. Arts Psychother. 38, 276-280. doi: 10.1016/j.aip.2011.08.007
37. Koch, S., and Fischman, D. (2011). Embodied enactive dance/movement therapy. Am. J. Dance Ther. 33, 57-72. doi: 10.1007/s10465-011-9108-4
38. Koch, S., Kunz, T., Lykou, S., and Cruz, R. (2014). Effects of dance movement therapy and dance on health-related psychological outcomes: a meta-analysis. Arts Psychother. 41, 46-64. doi: 10.1016/j.aip.2013.10.004
39. Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., and Reise, S. P. (2013). The clinical assessment interview for negative symptoms (CAINS): final development and validation. Am. J. Psychiatry 170, 165-172. doi: 10.1176/appi.ajp.2012.12010109
40. Kukla, F., and Gold, R. (1991). Schizophrene Minussymptomatik und ihre Erfassungsmethodik. Fortschr. Neurol. Psychiatr. 59, 60-66. doi: 10.1055/s-2007-1000680
41. Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., and Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373, 31-41. doi: 10.1016/S0140-6736(08)61764-X
42. Leucht, S., Pitschel-Walz, G., Abraham, D., and Kissling, W. (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. a meta-analysis of randomized controlled trials. Schizoph. Res. 35, 51-68. doi: 10.1016/S0920-9964(98)00105-4
43. Levine, S. Z., and Leucht, S. (2013). Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms. Schizophr. Res. 145, 125-127. doi: 10.1016/j.schres.2012.12.032
44. Liddle, P. F. (2000). "Descriptive clinical features of schizophrenia, " in New Oxford Textbook of Psychiatry, eds M. G. Gelder, N. C. Andreasen, J. J. Lopez-Ibor, and J. Geddes (New York, NY: Oxford University Press), 571-576.
45. National Collaborating Centre for Mental Health (NCCMH) (2014). Psychosis and Schizophrenia in Adults: The Nice Guidelines on Treatment and Management. London.
46. Merleau-Ponty, M. (1962). Phenomenology of Perception. New York, NY: Routledge.
47. Overall, J. E., and Gorham, D. R. (1962). The brief psychiatric rating scale. Psychol. Rep. 10, 799-812. doi: 10.2466/pr0.1962.10.3.799
48. Parnas, J. (2003). "Self and schizophrenia: a phenomenological perspective, " in The Self in Neuroscience and Psychiatry, eds T. Kircher and A. David (Cambridge: Cambidge University Press), 217-241.
49. Peralta, V., Cuesta, M. J., and De Leon, J. (1995). Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems. Psychol. Med. 25, 43-50. doi: 10.1017/S0033291700028075
50. Priebe, S., Savill, M., Reininghaus, U., Wykes, T., Bentall, R., Lauber, C., et al. (2013). Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia-a multi-centre randomised controlled trial. BMC Psychiatry 13:26. doi: 10.1186/1471-244X-13-26
51. Rabany, L., Weiser, M., Werbeloff, N., and Levkovitz, Y. (2011). Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophr. Res. 126, 226-230. doi: 10.1016/j.schres.2010.09.023
52. Rector, N. A., Seeman, M. V., and Segal, Z. V. (2003). Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophr. Res. 63, 1-11. doi: 10.1016/S0920-9964(02)00308-0
53. Röhricht, F. (2009). Body oriented psychotherapy. the state of the art in empirical research and evidence-based practice: a clinical perspective. Body Mov. Dance Psychother. 4, 135-156. doi: 10.1080/17432970902857263
54. Röhricht, F., and Papadopoulos, N. (2010). A Treatment Manual: Body Oriented Psychological Therapy for Chronic Schizophrenia. London: Newham Centre for Mental Health.
55. Röhricht, F., Papadopoulos, N., Holden, S., Clarke, T., and Priebe, S. (2011). Therapeutic processes and clinical outcomes of body psychotherapy in chronic schizophrenia-an open clinical trial. Arts Psychother. 38, 196-203. doi: 10.1016/j.aip.2011.06.001
56. Röhricht, F., Papadopoulos, N., Suzuki, I., and Priebe, S. (2009). Ego-pathology, body experience, and body psychotherapy in chronic schizophrenia. Psychol. Psychother. Theor. Res. Pract. 82, 19-30. doi: 10.1348/147608308X342932
57. Röhricht, F., and Priebe, S. (2006). Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychol. Med. 36, 669-678. doi: 10.1017/S0033291706007161
58. Sass, L. A. (2000). "Schizophrenia, self-experience, and so-called "negative symptoms" reflections on hyperreflexivity, " in Exploring The Self: Philosophical and Psychopathological Perspectives on Self-Experience, ed D. Zahavi (Amsterdam: John Benjamins), 149-182.
59. Sass, L. A., and Parnas, J. (2003). Schizophrenia, consciousness, and the self. Schizophr. Bull. 29, 427-444. doi: 10.1093/oxfordjournals.schbul.a007017
60. Simpson, G. M., and Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 45, 11-19. doi: 10.1111/j.1600-0447.1970.tb02066.x
61. Singh, S. P., Singh, V., Kar, N., and Chan, K. (2010). Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br. J. Psychiatry 197, 174-179. doi: 10.1192/bjp.bp.109.067710
62. Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., et al. (2009). Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393. doi: 10.1136/bmj.b2393
63. Suresh, K. P. (2011). An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J. Hum. Reprod. Sci. 4, 8-11. doi: 10.4103/0974-1208.82352
64. Tschacher, W., Munt, M., and Storch, M. (2014). Die Integration von Tanz, Bewegung und Psychotherapie durch den Embodimentansatz. Körper-Tanz-Bewegung 2, 54-63. doi: 10.2378/ktb2014.art10d
65. van Ginkel, J. R. (2014). SPSS Syntax for Applying Rules for Combining Multivariate Estimates in Multiple Imputation. Leiden University.
66. van Ginkel, J. R., and Kroonenberg, P. M. (2014). Analysis of variance of multiply imputed data. Multivariate Behav. Res. 49, 78-91. doi: 10.1080/00273171.2013.855890
67. Wittchen, H. U., Wunderlich, U., Gruschwitz, S., and Zaudig, M. (1997). SKID-I: Strukturiertes Klinisches Interview für DSM-IV. Göttingen: Hogrefe.
68. Xia, J., and Grant, T. J. (2009). Dance therapy for schizophrenia. Cochrane Database Syst. Rev. CD006868. doi: 10.1002/14651858.cd006868.pub2